Financial Disclosure

MetaTech AP Revenue Up 21% to NT$1.391B, Eyes Regenerative Medicine

Image
MetaTech AP Revenue Up 21% to NT$1.391B, Eyes Regenerative Medicine

Taipei – October 15, 2026 -- MetaTech AP Inc. (TPEx: 3224) reported revenue of NT$1.391 billion for the first nine months of 2026, up 21% year over year. The company outlined its 2027 strategy at an investor conference, with electronics and biomedicine as its two growth engines.

Electronics revenue rises 24.7% on AI server and power supply demand

The electronics business grew 24.7% year over year in the first nine months. MetaTech AP is pursuing opportunities in AI servers, power supplies and semiconductors. For 2027, it plans to strengthen AI-related applications and sales in the segment.

TAL Education Sets Oct. 29 Date for Fiscal Q2 2027 Results

Beijing – October 15, 2026 -- TAL Education Group (NYSE: TAL) will release unaudited results for the second quarter of fiscal year 2027 before the U.S. market opens on Thursday, October 29, 2026. The quarter ended August 31, 2026.

TAL schedules live call for 8:00 a.m. Eastern on October 29

The China-based smart learning solutions provider will host a conference call and live webcast at 8:00 a.m. U.S. Eastern Time, which is 8:00 p.m. in Beijing. The call follows the results release on the same day.

Participants must pre-register to join the call

Dial-in access requires advance registration. Registrants receive an email with dial-in numbers, a passcode and a unique access PIN. Registration stays open at any time, including up to and after the call start time.

Iberdrola, BBVA, Santander Close €150M Loan Fully on Blockchain

Image
Iberdrola, BBVA, Santander Close €150M Loan Fully on Blockchain

Madrid – October 15, 2026 -- Iberdrola, BBVA and Santander have arranged a €150 million syndicated loan whose entire lifecycle is administered on distributed ledger technology (DLT), the first live syndicated facility to be run that way.

Platform handles every stage from execution to maturity

The facility covers execution, disbursement, interest, waivers, repayments, assignments and maturity on a single blockchain-based platform. ioBuilders developed the platform together with BBVA and Santander. Gómez-Acebo & Pombo acted as legal advisers.

The platform also manages interest calculation and notification, principal and fee payments, early repayments, monitoring of financial covenants and information undertakings, certain contractual consents, and transfers of participations between lenders. Authorised participants see all events in real time. The agent bank retains operational control of the financing.

Ericsson Q3 Sales Rise 7% Organically as Net Income Halves

Stockholm – October 15, 2026 -- Ericsson posted organic sales growth of 7% in the third quarter of 2026, lifting reported sales to SEK 59.5 billion from SEK 56.2 billion a year earlier, while net income fell to SEK 5.8 billion from SEK 11.3 billion because the prior-year period included a large divestment gain.

Networks drives growth in three of four market areas

Organic sales rose in three out of four market areas, primarily on higher sales in Networks. Adjusted gross income increased to SEK 28.4 billion from SEK 27.0 billion, driven by Mobile Networks. Reported gross income was SEK 28.0 billion, against SEK 26.8 billion a year earlier.

Nordea Q3 ROE Hits 15.1% as AuM Climbs 13% to Record EUR 509bn

Helsinki – October 15, 2026 -- Nordea Bank Abp posted a third-quarter return on equity of 15.1% and earnings per share of EUR 0.35, while assets under management rose 13% year on year to a record EUR 509bn. Operating profit fell 4% to EUR 1.5bn.

Total income rises 2% to EUR 3.0bn as fee growth offsets weaker trading

Net fee and commission income increased 9% year on year, driven by a 14% rise in savings income. Net interest income grew 1% both year on year and quarter on quarter, as volume growth was partly offset by lower lending margins.

Net fair value result dropped 19%, which Nordea attributed to extraordinary interest rate volatility late in the quarter. Costs excluding regulatory fees were flat when adjusted for foreign exchange effects, and the cost-to-income ratio, excluding regulatory fees, stood at 45.0%.

Sinch to Publish Q3 2026 Report on Nov. 5 Under Acting CEO

Stockholm – October 15, 2026 -- Sinch AB (publ) will publish its interim report for the third quarter of 2026 on Thursday, November 5, 2026, at 07:30 CET, with Acting CEO and CFO Jonas Dahlberg leading the earnings presentation.

Sinch schedules Q3 earnings call for 10:00 CET, 2.5 hours after the release

The conference call and webcast begin at 10:00 CET on the same day. Dahlberg, who holds the roles of Acting CEO and CFO, will present the report together with Sofia Ohlander, SVP Corporate Control. A Q&A session will follow the presentation.

Investors can question management by phone or webcast

Participants who register for the teleconference receive dial-in numbers and a conference ID, and can ask questions verbally. The live webcast allows viewers to follow the presentation and submit written questions.

Nedap Q3 Revenue Rises 7% as Recurring Revenue Climbs 17%

Image
Nedap Q3 Revenue Rises 7% as Recurring Revenue Climbs 17%

Groenlo – October 15, 2026 -- Nedap grew third-quarter 2026 revenue by 7% year on year, with its four key markets up 9% and year-to-date key-market growth at 12%. Recurring revenue rose 17% in the first nine months of 2026 and made up 42% of total revenue for the period.

Recurring revenue grew faster than total revenue and increased in all four key markets in the quarter. CEO Rob Schuurman said the company remains on track with its Step Up! strategy.

Livestock revenue falls on delivery timing and subscription shift

Livestock revenue declined against a strong third quarter of 2025. Nedap attributes the drop mainly to delivery timing and a further move toward subscription-based offerings. Recurring revenue in the unit rose as adoption of as-a-service offerings grew, and the installed base expanded across multiple regions.

Community Healthcare Trust to Report Q3 Results on Nov. 3

Franklin, Tenn. – October 15, 2026 -- Community Healthcare Trust Incorporated (NYSE: CHCT) will report third-quarter 2026 results after the market closes on Tuesday, October 15, 2026, giving investors a fresh look at a portfolio of about $1.2 billion in outpatient healthcare real estate.

CHCT schedules earnings call for 9:00 a.m. Central on November 4

Management will hold a conference call on October 15, 2026, at 9:00 a.m. Central Time. The agenda covers earnings results, quarterly activities, general operations and industry trends. A simultaneous webcast will run through the Investor Relations section of the company's website, and a replay will be available afterward.

Dial-in access is available domestically, internationally and through a separate Canada toll-free line. A separate set of replay numbers is also provided.

J&T Express Q3 Parcel Volume Hits 9.58 Billion, Up 24.8% YoY

Hong Kong – October 15, 2026 -- J&T Global Express Limited (01519.HK) handled 9.58 billion parcels in the third quarter ended 30 September 2026, up 24.8% year on year, lifting average daily volume to 104.2 million. The figure is the second consecutive quarter above 100 million parcels per day.

For the first nine months of 2026, global volume reached 27.09 billion parcels, up 25.0% YoY, with a daily average of 99.2 million.

Southeast Asia volume rises 44.5% to 2.89 billion parcels in Q3

J&T Express kept its leading position in Southeast Asia, where average daily volume reached 31.4 million. Nine-month volume in the region totaled 8.41 billion parcels, up 61.0% YoY.

The company expanded regional capacity during the period. Sorting centers in Southeast Asia rose by 10 from the end of 2025 to 131. Line-haul vehicles increased by about 100 to 5,900, and automated sorting lines grew by 17 to 81.

Hi-TECH Beauty Labs Wins Patent, Seeks $5M SEED Round

Image
Hi-TECH Beauty Labs Wins Patent, Seeks $5M SEED Round

Dallas – October 15, 2026 -- Hi-TECH Beauty Labs, Corp. (HTBL) is pursuing a $5 million SEED round after the U.S. patent office issued Patent No. 12,642,834 B2 for B3 Technology®, a botanical platform for problem skin that avoids benzoyl peroxide, salicylic acid, adapalene and retinol.

The patent was issued October 15, 2026. HTBL will present its commercialization strategy and capital opportunity at the Global Capital Network Investor Conference on October 15, 2026, at the Renaissance Newport Beach Hotel in Newport Beach, California.

Patent covers three botanical ingredients

The patent protects B3 Technology®, which incorporates Black Willow Bark (Salix nigra), Cat's Claw (Uncaria tomentosa) and Dragon's Blood (Croton lechleri). HTBL describes the formulation as 100% natural and positions it as an alternative to acid-based formulations for problem skin and aging skin.